Press "Enter" to skip to content

New patent expiration for Mainpointe drug TUXARIN ER

0
Copyright © DrugPatentWatch. Originally published at New patent expiration for Mainpointe drug TUXARIN ER

Annual Drug Patent Expirations for TUXARIN+ER
Annual Drug Patent Expirations for TUXARIN+ER

Tuxarin Er is a drug marketed by Mainpointe and is included in one NDA. It is available from two suppliers. There are four patents protecting this drug.

This drug has fifty-six patent family members in eleven countries.

The generic ingredient in TUXARIN ER is chlorpheniramine maleate; codeine phosphate. Two suppliers are listed for this compound. Additional details are available on the chlorpheniramine maleate; codeine phosphate profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Copyright © DrugPatentWatch. Originally published at New patent expiration for Mainpointe drug TUXARIN ER
Do NOT follow this link or you will be banned from the site!